Skip to Content
Søk Menu

Filgotinib viser lovende resultater i behandling av RA-pasienter i fase III-studie

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Managing Risks with Newer Oral Small Molecules in Patients with IBD

/ Parakkal Deepak
IBDJAK-hemmere Play the Video 10:38

Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases

/ Sofie Larsen Rasmussen
Revmatoid artrittVaksinasjon
Rasmus Westermann

Cancer Risk in Rheumatoid Arthritis Patients Treated with Non-TNFi bDMARDs

/ Rasmus Westermann
KreftRevmatoid artrittSCR23 Play the Video 7:28
Espen Haavardsholm

Rheumatoid Arthritis – What Is New From SCR23?

/ Espen Haavardsholm
Revmatoid artrittSCR23 Play the Video 03:17

How Do Employers Support Their Employees with Inflammatory Arthritis?

/ Christina Merete Tvede Madsen
Danish Centre for Expertise in RheumatologyPsoriasisartritRevmatoid artritt Play the Video 03:50
Rasmus Westermann

Does JAKi Increase the Risk of Cancer in Patients with RA?

/ Rasmus Westermann
EULAR23KreftRevmatoid artritt Play the Video 04:50
Julie Katrine Bjørk Karstensen

Lifestyle, Cardiovascular Screening and Health in Patients with RA

/ Julie Katrine Bjørk Karstensen
Danish Centre for Expertise in RheumatologyHjerte- og karsykdomRevmatoid artritt Play the Video 04:00

EULAR 2023 – UPDATE

/ BestPractice Nordic
EULAR23OsteoporosePsoriasisartritRevmatoid artritt

Treatment after JAK Inhibitor in Patients with Rheumatoid Arthritis – What to do Next?

/ Jan Andreasen
JAK-hemmereRevmatoid artritt
Back to top